Vancomycin-associated acute kidney injury: a cross-sectional study from a single center in china

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-HPS-158
• By: ZHOU, Ying (Peking University First Hospital, Department of Pharmacy, Beijing, China)
• Co-author(s): Ying ZHOU: Department of Pharmacy, Peking University First Hospital, Beijing, China
  Li YANG: Department of Nephrology, Peking University First Hospital, Beijing, China
  Yimin CUI: Department of Pharmacy, Peking University First Hospital, Beijing, China
  
• Abstract:

  Background

  AKI is still the main serious ADR experienced by patients receiving VAN treatment. Some studies have reported AKI incidences of up to 40%.it is clinically important to confirm the risk factors for VA-AKI to help guide clinicians toward the more rational administration of VAN.

  Purpose

  The objective of this study was to investigate the..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login